A Cost-Effectiveness Analysis of Comprehensive Smoking-Cessation Interventions Based on the Community and Hospital Collaboration

被引:1
|
作者
Qin, Tingting [1 ]
Jin, Qianying [1 ]
Li, Xingming [1 ]
Bai, Xinyuan [1 ]
Qiao, Kun [1 ]
Gu, Mingyu [1 ]
Wang, Yao [1 ]
机构
[1] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
cost-effectiveness; smoking cessation; pharmacological intervention; online health promotion; community health centers; CHINA; MORTALITY; PROGRAM; FEASIBILITY; PREVALENCE; STROKE; TRENDS;
D O I
10.3389/fpubh.2022.853438
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThe prevalence of cigarette smoking in China is high and the utilization of smoking cessation clinics is very low. Multicomponent smoking cessation interventions involving community and hospital collaboration have the potential to increase the smoking cessation rate. However, the cost-effectiveness of this intervention model is unknown. MethodsWe conducted a smoking cessation intervention trial in 19 community health service centers in Beijing, China. A cost-effectiveness analysis was performed from a societal perspective to compare three strategies of smoking cessation: no intervention (NI), pharmacological intervention (PI), and comprehensive intervention (CI) (PI plus online health promotion). A Markov model, with a time horizon of 20 years, was used to simulate the natural progression of estimated 10,000 male smokers. A cross-sectional survey was conducted to obtain data on costs and quality-adjusted life years (QALYs) by using the five-level EuroQol-5-dimension (EQ-5D-5L) questionnaire. Probabilistic sensitivity analysis was performed to explore parameters of uncertainty in the model. ResultsA total of 680 participants were included in this study, including 283 in the PI group and 397 in the CI group. After 6 months of follow-up, the smoking cessation rate reached 30.0% in the CI group and 21.2% in the PI group. Using the Markov model, compared with the NI group, the intervention strategies of the PI group and the CI group were found to be cost-effective, with an incremental cost-effectiveness ratio (ICER) of $535.62/QALY and $366.19/QALY, respectively. The probabilistic sensitivity analysis indicated that the CI strategy was always the most cost-effective intervention. ConclusionCI for smoking cessation, based in hospital and community in China, is more cost-effective than PI alone. Therefore, this smoking cessation model should be considered to be implemented in healthcare settings.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] A Cost-Effectiveness Analysis of Smoking-Cessation Interventions Prior to Posterolateral Lumbar Fusion
    Zhuang, Thompson
    Ku, Seul
    Shapiro, Lauren M.
    Hu, Serena S.
    Cabell, Akaila
    Kamal, Robin N.
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2020, 102 (23): : 2032 - 2042
  • [2] Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice
    Tran, MT
    Holdford, DA
    Kennedy, DT
    Small, RE
    [J]. PHARMACOTHERAPY, 2002, 22 (12): : 1623 - 1631
  • [3] COST-EFFECTIVENESS ANALYSIS OF SMOKING CESSATION INTERVENTIONS IN MALAYSIA
    Neoh, C. F.
    Ibrahim, N. H.
    Ismail, H.
    Hong, Y. H.
    [J]. VALUE IN HEALTH, 2018, 21 : S234 - S235
  • [4] Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists
    Cantor, Scott B.
    Deshmukh, Ashish A.
    Luca, Nancy Stancic
    Nogueras-Gonzalez, Graciela M.
    Rajan, Tanya
    Prokhorov, Alexander V.
    [J]. ADDICTIVE BEHAVIORS, 2015, 45 : 79 - 86
  • [5] Cost-effectiveness of the Danish smoking cessation interventions: Subgroup analysis based on the Danish Smoking Cessation Database
    Olsen K.R.
    Bilde L.
    Juhl H.H.
    Kjaer N.T.
    Mosbech H.
    Evald T.
    Rasmussen M.
    Hiladakis H.
    [J]. The European Journal of Health Economics, 2006, 7 (4) : 255 - 264
  • [6] SMOKING-CESSATION ACROSS BORDERS: TRANSFERABILITY OF COST-EFFECTIVENESS RESULTS
    Vemer, P.
    Rutten-van Molken, M. P.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A459 - A459
  • [7] Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment
    Heitjan, D. F.
    Asch, D. A.
    Ray, Riju
    Rukstalis, Margaret
    Patterson, Freda
    Lerman, C.
    [J]. PHARMACOGENOMICS JOURNAL, 2008, 8 (06): : 391 - 399
  • [8] Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand
    Tosanguan, Jiraboon
    Chaiyakunapruk, Nathorn
    [J]. ADDICTION, 2016, 111 (02) : 340 - 350
  • [9] Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment
    D F Heitjan
    D A Asch
    Riju Ray
    Margaret Rukstalis
    Freda Patterson
    C Lerman
    [J]. The Pharmacogenomics Journal, 2008, 8 : 391 - 399
  • [10] Cost-effectiveness of a hospital-based smoking cessation intervention
    Meenan, RT
    Stevens, VJ
    Hornbrook, MC
    La Chance, PA
    Glasgow, RE
    Hollis, JF
    Lichtenstein, E
    Vogt, TM
    [J]. MEDICAL CARE, 1998, 36 (05) : 670 - 678